Skip to main content
. 2021 Aug 14;16:5513–5529. doi: 10.2147/IJN.S322688

Figure 5.

Figure 5

In vivo toxicities of tested compounds and nanoparticles to BALB/c mice. (A) The body weight of the mice during the treatment. (B) Drug accumulation in liver and kidney. (C) The H&E staining of slices from heart, liver, spleen, lung and kidney.

Notes: *P<0.01, **P<0.001.

Abbreviations: NPs, nanoparticles; H&E, hematoxylin and eosin.